🔎 Trials Near Me

Akèy › Kansè Ipofaringe › Kalifòni › Los Angeles

Etid klinik pou Kansè Ipofaringe nan Los Angeles, CA

3 etid pou Kansè Ipofaringe ap chèche patisipan nan sit nan ak bò kote Los Angeles (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Ap rekriteFaz 2
  • The Angeles Clinic and Research Institute - West Los Angeles Office, Los Angeles
  • Los Angeles General Medical Center, Los Angeles
  • USC / Norris Comprehensive Cancer Center, Los Angeles
  • ak 1 plis
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT05136196

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

Ap rekriteFaz 3
  • USC / Norris Comprehensive Cancer Center, Los Angeles
  • Cedars-Sinai Medical Center, Los Angeles
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT07441681

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Ap rekriteFaz 1/2
  • California Research Institute, Los Angeles
  • Valkyrie Clinical Trials, Los Angeles
Laj 18 ak plis · Tout sèks · Mizajou Jul 29, 2026 · NCT04198766

Etid Kansè Ipofaringe nan lòt vil

Lòt etid nan Los Angeles

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.